S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
NASDAQ:THTX

Theratechnologies (THTX) Stock Price, News & Analysis

$1.66
+0.20 (+13.70%)
(As of 03/28/2024 ET)
Today's Range
$1.45
$1.66
50-Day Range
$1.18
$2.01
52-Week Range
$0.88
$4.30
Volume
62,500 shs
Average Volume
33,516 shs
Market Capitalization
$40.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
THTX stock logo

About Theratechnologies Stock (NASDAQ:THTX)

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

THTX Stock Price History

THTX Stock News Headlines

This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Theratechnologies: Fiscal Q4 Earnings Snapshot
Will This Dual-Listed Bio-Pharma Catch New Year Action?
FDA Approves Theratechnologies' Trogarzo 90-second IV Push Loading Dose
FDA Approves Theratechnologies' Trogarzo 90-second IV Push Loading Dose
See More Headlines
Receive THTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/29/2024
Next Earnings (Estimated)
4/10/2024
Fiscal Year End
11/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:THTX
Employees
103
Year Founded
1993

Profitability

Net Income
$-23,960,000.00
Pretax Margin
-28.78%

Debt

Sales & Book Value

Annual Sales
$81.76 million
Book Value
($0.86) per share

Miscellaneous

Free Float
N/A
Market Cap
$40.17 million
Optionable
Optionable
Beta
1.31

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Paul Lévesque (Age 59)
    President, CEO & Director
    Comp: $1.18M
  • Mr. Philippe Dubuc M.B.A. (Age 57)
    MBA, Senior VP & CFO
    Comp: $432.31k
  • Mr. Jocelyn Lafond L.L.M. (Age 56)
    LL.B., General Counsel & Corporate Secretary
    Comp: $316.29k
  • Dr. Christian Marsolais Ph.D. (Age 61)
    Senior VP & Chief Medical Officer
    Comp: $434.61k
  • Mr. John Leasure (Age 59)
    Global Commercial Officer
    Comp: $420.91k
  • Hon. Andre Dupras M.Sc. (Age 60)
    Vice President of Human Resources

THTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" THTX shares.
View THTX analyst ratings
or view top-rated stocks.

How have THTX shares performed in 2024?

Theratechnologies' stock was trading at $1.62 on January 1st, 2024. Since then, THTX shares have increased by 2.5% and is now trading at $1.66.
View the best growth stocks for 2024 here
.

Are investors shorting Theratechnologies?

Theratechnologies saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 17,100 shares, a decrease of 35.7% from the February 29th total of 26,600 shares. Based on an average daily volume of 74,500 shares, the short-interest ratio is currently 0.2 days. Currently, 0.1% of the company's shares are short sold.
View Theratechnologies' Short Interest
.

When is Theratechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 10th 2024.
View our THTX earnings forecast
.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc. (NASDAQ:THTX) posted its earnings results on Wednesday, February, 21st. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.16. The business had revenue of $23.45 million for the quarter. During the same period in the previous year, the firm posted ($0.36) earnings per share.

When did Theratechnologies' stock split?

Shares of Theratechnologies reverse split before market open on Monday, July 31st 2023. The 1-4 reverse split was announced on Monday, July 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What guidance has Theratechnologies issued on next quarter's earnings?

Theratechnologies issued an update on its FY 2024 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $87.0 million-$90.0 million, compared to the consensus revenue estimate of $91.4 million.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Trevena (TRVN), Citius Pharmaceuticals (CTXR), Great Panther Mining (GPL), TherapeuticsMD (TXMD), Advanced Micro Devices (AMD), Bionano Genomics (BNGO), ChromaDex (CDXC), Caladrius Biosciences (CLBS) and Chimerix (CMRX).

Who are Theratechnologies' major shareholders?

Theratechnologies' stock is owned by many different retail and institutional investors. Top institutional investors include AIGH Capital Management LLC (15.37%), Nantahala Capital Management LLC (11.08%), Worth Venture Partners LLC (3.75%), National Bank of Canada FI (0.47%), Stifel Financial Corp (0.29%) and Wealthspire Advisors LLC (0.21%).

How do I buy shares of Theratechnologies?

Shares of THTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Theratechnologies have any subsidiaries?
The following companies are subsidiares of Theratechnologies: Katana, Pharma-G Inc., Theratechnologies Europe Inc., Theratechnologies Europe Limited, Theratechnologies Intercontinental Inc., and Theratechnologies U.S. Inc.
Read More
This page (NASDAQ:THTX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners